Cargando…

Correction to: Dysregulation of astrocytic Ca(2+) signaling and gliotransmitter release in mouse models of α-synucleinopathies

Detalles Bibliográficos
Autores principales:	Nanclares, Carmen, Poynter, Jonah, Martell-Martinez, Hector A., Vermilyea, Scott, Araque, Alfonso, Kofuji, Paulo, Lee, Michael K., Covelo, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175350/ https://www.ncbi.nlm.nih.gov/pubmed/37083838 http://dx.doi.org/10.1007/s00401-023-02573-1

Ejemplares similares

Dysregulation of astrocytic Ca(2+) signaling and gliotransmitter release in mouse models of α-synucleinopathies
por: Nanclares, Carmen, et al.
Publicado: (2023)

Calcium signaling in astrocytes and gliotransmitter release
por: Goenaga, Julianna, et al.
Publicado: (2023)

Neuronal activity determines distinct gliotransmitter release from a single astrocyte
por: Covelo, Ana, et al.
Publicado: (2018)

Dysregulation of Astrocyte–Neuronal Communication in Alzheimer’s Disease
por: Nanclares, Carmen, et al.
Publicado: (2021)

Amyloid pathology disrupts gliotransmitter release in astrocytes
por: Pillai, Anup Gopalakrishna, et al.
Publicado: (2022)

Arsenic exposure and glutamate-induced gliotransmitter release from astrocytes☆
por: Wang, Yan, et al.
Publicado: (2012)

Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of α-synucleinopathy
por: Singh, Balvindar, et al.
Publicado: (2019)

What do we know about gliotransmitter release from astrocytes?
por: Sahlender, Daniela A., et al.
Publicado: (2014)

Gliotransmitter Release from Astrocytes: Functional, Developmental, and Pathological Implications in the Brain
por: Harada, Kazuki, et al.
Publicado: (2016)

Astrocyte-Mediated Neuronal Synchronization Properties Revealed by False Gliotransmitter Release
por: Pirttimaki, Tiina M., et al.
Publicado: (2017)

Optogenetic and Chemogenetic Approaches for Studying Astrocytes and Gliotransmitters
por: Bang, Juwon, et al.
Publicado: (2016)

Loss of tau expression attenuates neurodegeneration associated with α-synucleinopathy
por: Vermilyea, Scott C., et al.
Publicado: (2022)

Gut Microbiota Metabolites Differentially Release Gliotransmitters from the Cultured Human Astrocytes: A Preliminary Report
por: Karbownik, Michał Seweryn, et al.
Publicado: (2023)

α7 Nicotinic Receptor-Mediated Astrocytic Gliotransmitter Release: Aβ Effects in a Preclinical Alzheimer’s Mouse Model
por: Pirttimaki, Tiina Maria, et al.
Publicado: (2013)

GABA as a rising gliotransmitter
por: Yoon, Bo-Eun, et al.
Publicado: (2014)

Glia and gliotransmitters on carbon nanotubes
por: Min, Joo-Ok, et al.
Publicado: (2017)

Astrocytes modulate sensory-evoked neuronal network activity
por: Lines, Justin, et al.
Publicado: (2020)

Sustained Na(+)/H(+) Exchanger Activation Promotes Gliotransmitter Release from Reactive Hippocampal Astrocytes following Oxygen-Glucose Deprivation
por: Cengiz, Pelin, et al.
Publicado: (2014)

Opioid-Mediated Astrocyte–Neuron Signaling in the Nucleus Accumbens
por: Corkrum, Michelle, et al.
Publicado: (2019)

Effects of Carbamazepine, Lacosamide and Zonisamide on Gliotransmitter Release Associated with Activated Astroglial Hemichannels
por: Fukuyama, Kouji, et al.
Publicado: (2020)

Altered calcium signaling in Bergmann glia contributes to spinocerebellar ataxia type-1 in a mouse model of SCA1
por: Nanclares, Carmen, et al.
Publicado: (2023)

Modulation of Gonadotropin-Releasing Hormone Neuron Activity and Secretion in Mice by Non-peptide Neurotransmitters, Gasotransmitters, and Gliotransmitters
por: Spergel, Daniel J.
Publicado: (2019)

Astrocytes in Neurodegenerative Diseases: A Perspective from Tauopathy and α-Synucleinopathy
por: Wang, Peng, et al.
Publicado: (2021)

Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
por: Alecu, Irina, et al.
Publicado: (2019)

D-serine as a gliotransmitter and its roles in brain development and disease
por: Horn, Marion R. Van, et al.
Publicado: (2013)

α-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment
por: Karim, Md. Razaul, et al.
Publicado: (2020)

Endocannabinoid signaling in synaptic function
por: Noriega‐Prieto, Jose Antonio, et al.
Publicado: (2022)

Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
por: Brás, Inês C., et al.
Publicado: (2021)

Ca(2+)-Dependent and Ca(2+)-Independent ATP Release in Astrocytes
por: Xiong, Yingfei, et al.
Publicado: (2018)

Autonomic Dysfunction in α-Synucleinopathies
por: Mendoza-Velásquez, José Javier, et al.
Publicado: (2019)

Selective vulnerability in α-synucleinopathies
por: Alegre-Abarrategui, Javier, et al.
Publicado: (2019)

Lysosomal exocytosis releases pathogenic α-synuclein species from neurons in synucleinopathy models
por: Xie, Ying Xue, et al.
Publicado: (2022)

Role of Microglia and Astrocytes in Alzheimer’s Disease: From Neuroinflammation to Ca(2+) Homeostasis Dysregulation
por: Di Benedetto, Giulia, et al.
Publicado: (2022)

Reinforcing Interdisciplinary Collaborations to Unravel the Astrocyte “Calcium Code”
por: Covelo, Ana, et al.
Publicado: (2022)

Immunotherapies in Huntington's disease and α-Synucleinopathies
por: Fatoba, Oluwaseun, et al.
Publicado: (2020)

Neurons and Glia Interplay in α-Synucleinopathies
por: Mavroeidi, Panagiota, et al.
Publicado: (2021)

Autophagy in α-Synucleinopathies—An Overstrained System
por: Fellner, Lisa, et al.
Publicado: (2021)

A Candidate Gliotransmitter, L-β-Aminoisobutyrate, Contributes to Weight Gain and Metabolic Complication Induced by Atypical Antipsychotics
por: Fukuyama, Kouji, et al.
Publicado: (2023)

A Novel Gliotransmitter, L-β-Aminoisobutyric Acid, Contributes to Pathophysiology of Clinical Efficacies and Adverse Reactions of Clozapine
por: Fukuyama, Kouji, et al.
Publicado: (2023)

Gaucher Disease and the Synucleinopathies
por: Hruska, Kathleen S., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_eeb8r1nq4kls50bllifv7s3eqn